Biomea Fusion, Inc.
Nasdaq: BMEAPharmaceutical Preparations · Entity-resolved by Clous
CIK0001840439
TickerBMEA
ExchangeNasdaq
SIC2834
StateDE
FY end12-31
Illustrative profile — live data lights up when a server API key is configured.
Key financials
Revenue
—
—
Net IncomeFY2025-12-31
-$61.8M
+55.4% YoY
Total AssetsFY2025-12-31
$58.57M
-26.7% YoY
EquityFY2025-12-31
$29.55M
-42.7% YoY
Shares OutstandingFY2025-12-31
72.3M
—
Operating Cash FlowFY2025-12-31
-$70.37M
+41.3% YoY
Short interest & fails
Cost to borrow2.13%200K shares availablehard to borrow
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Net Income | -$81.83M | -$117.26M | -$138.43M | -$61.8M | +55.4% | — |
| Total Assets | $129.31M | $199.93M | $79.94M | $58.57M | -26.7% | — |
| Equity | $108.54M | $169.24M | $51.57M | $29.55M | -42.7% | — |
| Operating Cash Flow | -$62.42M | -$96.59M | -$119.89M | -$70.37M | +41.3% | — |
| Shares Outstanding | — | — | — | 72.3M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001840439